Lester Porter
Medical Oncology · Nashville, TNNPI 1508890286
Payments from drug & device makers
Across 217 payments — averaging $21.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$595
- E.r. Squibb & Sons, L.L.C.$511
- Genentech USA, Inc.$447
- Novartis$289
- Regeneron Healthcare Solutions, Inc.$267
- Amgen$210
- plus $2K from 35 others
What the payments were for
- Food & beverage$4,57399%
- Education$291%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 19 | $595 |
| E.r. Squibb & Sons, L.L.C. | 23 | $511 |
| Genentech USA, Inc. | 15 | $447 |
| Novartis | 18 | $289 |
| Regeneron Healthcare Solutions, Inc. | 4 | $267 |
| Amgen | 11 | $210 |
| AstraZeneca(2 entities) | 13 | $203 |
| Seagen Inc. | 6 | $183 |
| Bayer | 9 | $175 |
| Adaptive Biotechnologies Corporation | 1 | $115 |
| Pfizer | 8 | $114 |
| Astellas Pharma US Inc | 6 | $101 |
| Eisai Inc. | 5 | $97 |
| Sanofi | 6 | $97 |
| Tesaro, Inc. | 3 | $96 |
| Johnson & Johnson | 6 | $89 |
| Incyte Corporation | 6 | $83 |
| Gilead | 5 | $82 |
| Pharmacyclics LLC, An Abbvie Company | 5 | $81 |
| Lilly USA, LLC | 6 | $76 |
| Teva Pharmaceuticals USA, Inc. | 5 | $73 |
| Clovis Oncology, Inc. | 5 | $68 |
| Aurobindo Pharma USA, Inc. | 3 | $66 |
| Bristol Myers Squibb | 3 | $61 |
| Array Biopharma Inc | 3 | $53 |
| EMD Serono, Inc. | 4 | $50 |
| AbbVie | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| Spectrum Pharmaceuticals Inc. | 1 | $27 |
| Taiho Oncology, Inc. | 1 | $26 |
| Exelixis Inc. | 2 | $26 |
| Heron Therapeutics, Inc. | 1 | $25 |
| Rigel Pharmaceuticals, Inc. | 1 | $24 |
| Verastem, Inc. | 2 | $23 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
| GSK | 1 | $18 |
| Lexicon Pharmaceuticals, Inc. | 1 | $17 |
| Tersera Therapeutics LLC | 1 | $15 |
| Secura Bio, Inc. | 1 | $14 |
| Foundation Medicine, Inc. | 1 | $13 |
| Dova Pharmaceuticals | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,602 in reported general payments places this provider in the 35th percentile of 101 medical oncology providers in Tennessee.
Other medical oncology in Nashville
- Melissa JohnsonNashville$46M
- David SpigelNashville$29.7M
- Howard BurrisNashville$12.2M
- Ingrid MayerNashville$6.3M
- Jennifer ChoeNashville$4.1M
- Cathy EngNashville$3.8M
- Jordan BerlinNashville$3.7M
- Kristen CiomborNashville$3.2M
- Vandana AbramsonNashville$3M
- Leora HornNashville$2.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.